QR Code

Cardiotoxicity related to intrapericardial infusion of bevacizumab in the treatment of lung cancer-mediated malignant pericardial effusion: a case report

BackgroundLung cancer can result in malignant pericardial effusion (MPE), impacting patient prognosis. Intrapericardial infusion of bevacizumab was an alternative treatment for MPE.Case presentationWe present the case of a 48-year-old female with stage IV lung adenocarcinoma and MPE. MPE was managed...

Full description

Saved in:
Main Authors: Shilong Wu, Yanjun Lu, Chenyang Xu, Huafeng Liu
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2025-10-01
Series:Frontiers in Pharmacology
Subjects:
bevacizumab
cardiotoxicity
myocardial ischemia
lung cancer
malignant pericardial effusion
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1573297/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items